Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DiagnaMed Holdings Corp DGNMF


Primary Symbol: C.DMED

Technology Software - Application
DiagnaMed Holdings Corp. is a Canada-based healthcare technology company focused on brain health using artificial intelligence (AI). The Company is commercializing BRAIN AGE Brain Health AI Platform, a consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. The BRAIN AGE Brain Health AI Platform (BRAIN AGE) leverages its electroencephalograph (EEG) data from research studies and future data collection and applying it to build a potential drug discovery and clinical research AI platform. The BRAIN AGE estimates brain age by recording brain-wave activity from multiple brain regions and calculating the data with a proprietary machine-learning model. The BRAIN AGE has the potential to accelerate patient recruitment for clinical trials, data analysis, drug development go/no-go decisions and new treatment options for neurological, psychiatric and infectious diseases.


CSE:DMED - Post by User

DiagnaMed Holdings Corp
<< Previous
 Bullboard Posts
User Avatar Image
(3018)
•••
Post by Betteryear2on Oct 30, 2024 8:18am
57 Views
Post# 36288298

DiagnaMed Advancing the Medical Potential of Hydrogen

DiagnaMed Advancing the Medical Potential of HydrogenTORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on brain health, announces its strategic initiative in advancing therapies that unlock the medical potential of molecular hydrogen for brain health.

DiagnaMed Advancing the Medical Potential of Hydrogen
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities